Unexplained Anaemia in Ageing Treatment Study
Anaemia is a common disease and its incidence increases with age. Approximately 17% of individuals >65 years are prone to anaemia which can be due to blood disorders, cancer, chronic kidney disease, and deficiency of vitamins (e.g. iron, vitamin B12 folate). Unexplained Anaemia in Ageing accounts for approximately one-third of anaemia in patients over 65 years of age and there is no effective approved treatment. Older people with anaemia are at high risk for decreased physical function, which is an independent predictor of decreased function, energy, and quality of life.
This clinical study is designed to determine the efficacy of the study medication for Unexplained Anaemia in Ageing.
Who can participate?
You may be eligible for this study if you:
- If you are >65 years of age
- Have been diagnosed with anaemia in the past
- Have had a recent blood test indicating anaemia
If you are eligible to be involved in the study, you will be asked to attend the clinic 15 times over a period of approximately 18 weeks. This includes a run-in period of up to 6 weeks followed by entering into the treatment phase of the study where you will receive study medication. You will be asked to take the medication once a day for approximately 12 weeks.
This study is currently looking for participants in NSW, VIC, QLD and WA.
If you would like to learn more, please click here and one of our clinical trials team will contact you.